Add BrightSurf on Google Email

Mechanobiology breakthrough reshapes understanding of atherosclerosis: Stacked endothelial cells transform into novel foam cells, unlocking new targets for anti-lipid and anti-inflammatory therapies

Researchers have discovered a new subtype of foam cells that form in early atherosclerosis, driven by mechanical stacking stress. These coralthelial cells promote inflammation and accelerate lesion development. The study offers promising therapeutic targets and novel prevention strategies for cardiovascular disease prevention.

SourceShanghai Jiao Tong University Journal Center·JournalMechanobiology in Medicine·TypeNews article·DateJun 5, 2026

Lab-grown human skin advances our understanding of the critical role of skin blood vessels in inflammation, repair, regeneration, and aging

Researchers have created lab-grown human skin organoids that can form complex microvascular networks similar to those in native human skin. These self-organizing structures function similarly to native skin, responding to inflammatory stimuli and re-growing after injury.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateApr 28, 2026

Study elucidates role of “G900” gene enhancers in asthma-associated inflammation

Researchers found that mice lacking the G900 region exhibit reduced inflammatory response and suppressed Th2 differentiation when exposed to allergens. This discovery highlights the importance of the G900 gene enhancer in regulating immune responses and has implications for personalized treatments and asthma care.

SourceChiba University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJun 24, 2024

Promising anti-inflammatory properties of black soldier fly larvae oil – implications on conditions such as ulcerative colitis

The study found that black soldier fly larvae oil exhibits anti-inflammatory properties, suppressing proinflammatory cytokines and improving colon health. BSFL oil's unique compound profile may offer a new approach to managing inflammatory diseases.

SourceThe Hebrew University of Jerusalem·JournalInternational Journal of Molecular Sciences·TypeExperimental study·DateAug 17, 2023

New strategy enables targeted treatment of rheumatoid arthritis

A new strategy for treating rheumatoid arthritis has been proposed, integrating small interfering RNAs and Prussian blue nanoparticles to silence proinflammatory cytokines and scavenge reactive oxygen species. The approach was tested in a mouse model, showing improved therapeutic efficacy and real-time monitoring capabilities.

SourceChinese Academy of Sciences Headquarters·JournalProceedings of the National Academy of Sciences·TypeMeta-analysis·DateOct 21, 2022